Rise Advisors, LLC Genmab A/S Transaction History
Rise Advisors, LLC
- $206 Million
- Q4 2024
A detailed history of Rise Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Rise Advisors, LLC holds 577 shares of GMAB stock, worth $12,290. This represents 0.01% of its overall portfolio holdings.
Number of Shares
577
Previous 577
-0.0%
Holding current value
$12,290
Previous $14,000
14.29%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
236Shares Held
56.3MCall Options Held
25.3KPut Options Held
33.4K-
Alliancebernstein L.P. New York, NY14.9MShares$318 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$108 Million0.0% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$60 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$59.8 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA2.57MShares$54.8 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...